Nu Skin Enterprises (NYSE:NUS) Upgraded at ValuEngine

ValuEngine upgraded shares of Nu Skin Enterprises (NYSE:NUS) from a strong sell rating to a sell rating in a report released on Thursday morning, ValuEngine reports.

A number of other equities analysts have also recently issued reports on the stock. Deutsche Bank raised shares of Nu Skin Enterprises from a hold rating to a buy rating and set a $60.00 price objective on the stock in a research report on Wednesday, May 1st. Bank of America reissued an underperform rating and set a $52.00 price objective (down previously from $57.00) on shares of Nu Skin Enterprises in a research report on Wednesday, June 19th. Citigroup cut their price objective on shares of Nu Skin Enterprises from $86.00 to $52.00 and set a buy rating on the stock in a research report on Thursday, July 18th. DA Davidson cut shares of Nu Skin Enterprises from a buy rating to a neutral rating and cut their price objective for the stock from $88.00 to $38.00 in a research report on Wednesday, July 17th. Finally, Jefferies Financial Group cut shares of Nu Skin Enterprises from a buy rating to a hold rating and set a $40.00 price objective on the stock. in a research report on Wednesday, July 17th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of $55.63.

Shares of NUS stock traded up $0.14 on Thursday, reaching $39.13. 553,592 shares of the company were exchanged, compared to its average volume of 891,424. The stock has a market capitalization of $2.16 billion, a P/E ratio of 11.12, a price-to-earnings-growth ratio of 1.07 and a beta of 0.67. The firm has a 50-day simple moving average of $45.17. The company has a current ratio of 1.86, a quick ratio of 1.10 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a one year low of $35.03 and a one year high of $88.68.

Several institutional investors and hedge funds have recently bought and sold shares of NUS. BlackRock Inc. raised its holdings in shares of Nu Skin Enterprises by 19.5% in the 1st quarter. BlackRock Inc. now owns 7,498,023 shares of the company’s stock worth $358,856,000 after acquiring an additional 1,224,725 shares during the last quarter. Norges Bank purchased a new stake in Nu Skin Enterprises in the 4th quarter valued at about $56,136,000. Delek Group Ltd. purchased a new stake in Nu Skin Enterprises in the 1st quarter valued at about $17,859,000. Federated Investors Inc. PA increased its stake in Nu Skin Enterprises by 739.1% in the 1st quarter. Federated Investors Inc. PA now owns 172,798 shares of the company’s stock valued at $8,270,000 after buying an additional 152,205 shares during the last quarter. Finally, First Trust Advisors LP increased its stake in Nu Skin Enterprises by 194.9% in the 2nd quarter. First Trust Advisors LP now owns 228,964 shares of the company’s stock valued at $11,293,000 after buying an additional 151,328 shares during the last quarter. Institutional investors own 77.20% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

See Also: What does a bar chart mean for investors?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.